D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 72 Citations 16,467 256 World Ranking 1087 National Ranking 491
Medicine D-index 72 Citations 16,540 266 World Ranking 16513 National Ranking 252

Overview

What is she best known for?

The fields of study she is best known for:

  • Acquired immunodeficiency syndrome
  • Internal medicine
  • Virus

Sabine Yerly mostly deals with Virology, Internal medicine, Immunology, Drug resistance and Viral disease. The various areas that Sabine Yerly examines in her Virology study include Reverse transcriptase and Epidemiology. Sabine Yerly has included themes like Surgery, Gastroenterology, Reverse-transcriptase inhibitor, Placebo and Ritonavir in her Internal medicine study.

Sabine Yerly has researched Immunology in several fields, including Bronchoalveolar lavage, Lung, Prospective cohort study and Respiratory system. Her Drug resistance research incorporates themes from Protease inhibitor and HIV drug resistance. Her specific area of interest is Viral disease, where Sabine Yerly studies Sida.

Her most cited work include:

  • Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. (423 citations)
  • Prevalence of Drug-Resistant HIV-1 Variants in Untreated Individuals in Europe: Implications for Clinical Management (389 citations)
  • Transmission of antiretroviral-drug-resistant HIV-1 variants (365 citations)

What are the main themes of her work throughout her whole career to date?

Her primary areas of study are Virology, Immunology, Internal medicine, Viral load and Drug resistance. Her Virus, Lentivirus, Sida, Viral disease and Zidovudine study are her primary interests in Virology. Her Viral disease study integrates concerns from other disciplines, such as Acquired immunodeficiency syndrome and Immunopathology.

She works mostly in the field of Immunology, limiting it down to topics relating to Transmission and, in certain cases, Pediatrics, as a part of the same area of interest. Her Internal medicine study combines topics in areas such as Gastroenterology, Oncology and Reverse-transcriptase inhibitor. Her Drug resistance research includes elements of Resistance mutation, Reverse transcriptase, Integrase, Genotype and Cohort.

She most often published in these fields:

  • Virology (43.08%)
  • Immunology (35.00%)
  • Internal medicine (30.38%)

What were the highlights of her more recent work (between 2017-2021)?

  • Internal medicine (30.38%)
  • Severe acute respiratory syndrome coronavirus 2 (5.77%)
  • Cohort study (16.54%)

In recent papers she was focusing on the following fields of study:

Her primary scientific interests are in Internal medicine, Severe acute respiratory syndrome coronavirus 2, Cohort study, Viral load and Coronavirus disease 2019. Her Internal medicine research is multidisciplinary, relying on both Gastroenterology and Dolutegravir. Her Severe acute respiratory syndrome coronavirus 2 study incorporates themes from Virology, Whole genome sequencing, Lineage specific, Antibody and Spike Protein.

Her study in Virology is interdisciplinary in nature, drawing from both Epitope, Antibody response and Peptide sequence. Her research integrates issues of Population level, Genotype and Antiretroviral therapy in her study of Viral load. Her work on Viremia as part of general Immunology research is frequently linked to Alpha interferon, thereby connecting diverse disciplines of science.

Between 2017 and 2021, her most popular works were:

  • Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. (423 citations)
  • Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland. (76 citations)
  • Validation of a commercially available SARS-CoV-2 serological immunoassay. (74 citations)

In her most recent research, the most cited papers focused on:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Virus

Sabine Yerly mainly focuses on Antibody, Severe acute respiratory syndrome coronavirus 2, Viral load, Virology and Coronavirus disease 2019. Her Severe acute respiratory syndrome coronavirus 2 research is multidisciplinary, incorporating perspectives in Humoral immunity, Cohort and Population study. As part of her Immunology and Genetics and Viral load studies, she is studying Viral load.

Her Viremia study in the realm of Immunology interacts with subjects such as Alpha interferon. Her work in the fields of Virology, such as Virus, intersects with other areas such as Protein Array Analysis. Her Coronavirus disease 2019 research includes themes of Gastroenterology, Longitudinal study and Serology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study.

Silvia Stringhini;Silvia Stringhini;Silvia Stringhini;Ania Wisniak;Giovanni Piumatti;Giovanni Piumatti;Andrew S Azman;Andrew S Azman.
The Lancet (2020)

953 Citations

Transmission of antiretroviral-drug-resistant HIV-1 variants

S Yerly;L Kaiser;E Race;J P Bru.
The Lancet (1999)

564 Citations

Prevalence of Drug-Resistant HIV-1 Variants in Untreated Individuals in Europe: Implications for Clinical Management

Annemarie M. J. Wensing;David A. van de Vijver;Gioacchino Angarano;Birgitta Åsjö.
The Journal of Infectious Diseases (2005)

563 Citations

Cohort profile: the Swiss HIV Cohort study

Franziska Schoeni-Affolter;Bruno Ledergerber;Martin Rickenbach;Christoph Rudin.
International Journal of Epidemiology (2010)

471 Citations

The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan

Victor DeGruttola;Lynn Dix;Richard D'Aquila;Dan Holder.
Antiviral Therapy (2000)

447 Citations

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

Selidji T Agnandji;Angela Huttner;Madeleine E Zinser;Patricia Njuguna.
The New England Journal of Medicine (2016)

441 Citations

Turnover of CD4+ and CD8+ T Lymphocytes in HIV-1 Infection as Measured by Ki-67 Antigen

Nicolas Sachsenberg;Alan S. Perelson;Sabine Yerly;Gérard A. Schockmel.
Journal of Experimental Medicine (1998)

393 Citations

A Controlled Trial of Zidovudine in Primary Human Immunodeficiency Virus Infection

Sabine Kinloch De Loës;Bernard J. Hirschel;Bruno Hoen;David A. Cooper.
The New England Journal of Medicine (1995)

350 Citations

Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis.

Ravindra K Gupta;Andrew Hill;Anthony W Sawyer;Alessandro Cozzi-Lepri.
Lancet Infectious Diseases (2009)

332 Citations

Acute HIV infection: impact on the spread of HIV and transmission of drug resistance.

S Yerly;S Vora;P Rizzardi;J P Chave.
AIDS (2001)

313 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Sabine Yerly

Huldrych F. Günthard

Huldrych F. Günthard

University of Zurich

Publications: 165

Enos Bernasconi

Enos Bernasconi

Universita della Svizzera Italiana

Publications: 122

Manuel Battegay

Manuel Battegay

University Hospital of Basel

Publications: 107

Matthias Cavassini

Matthias Cavassini

University of Lausanne

Publications: 107

Deenan Pillay

Deenan Pillay

University College London

Publications: 92

Douglas D. Richman

Douglas D. Richman

University of California, San Diego

Publications: 91

Anne-Mieke Vandamme

Anne-Mieke Vandamme

Rega Institute for Medical Research

Publications: 88

Rainer Weber

Rainer Weber

University of Zurich

Publications: 79

Hansjakob Furrer

Hansjakob Furrer

University of Bern

Publications: 76

Laurent Kaiser

Laurent Kaiser

Hôpitaux Universitaires de Genève

Publications: 71

David A. Cooper

David A. Cooper

University of New South Wales

Publications: 69

Tanja Stadler

Tanja Stadler

Swiss Institute of Bioinformatics

Publications: 69

Jacques Fellay

Jacques Fellay

École Polytechnique Fédérale de Lausanne

Publications: 68

Charles A. Boucher

Charles A. Boucher

Erasmus University Rotterdam

Publications: 67

Bruno Ledergerber

Bruno Ledergerber

University of Zurich

Publications: 66

Mark A. Wainberg

Mark A. Wainberg

McGill University

Publications: 66

Trending Scientists

Wenfei Fan

Wenfei Fan

University of Edinburgh

Martin I. Reiman

Martin I. Reiman

Columbia University

Qingguo Huang

Qingguo Huang

University of Georgia

Arvi Rauk

Arvi Rauk

University of Calgary

Wladek Walukiewicz

Wladek Walukiewicz

Lawrence Berkeley National Laboratory

Alexander S. Mankin

Alexander S. Mankin

University of Illinois at Chicago

Andrew T. D. Bennett

Andrew T. D. Bennett

Deakin University

Antoni R. Slabas

Antoni R. Slabas

Durham University

Stefan H. Heinemann

Stefan H. Heinemann

Friedrich Schiller University Jena

Jack Kohler

Jack Kohler

Norwegian Polar Institute

Yoko Yokouchi

Yoko Yokouchi

National Institute for Environmental Studies

Ian M. Franks

Ian M. Franks

University of British Columbia

Michael P. Whyte

Michael P. Whyte

Washington University in St. Louis

Christopher Chen

Christopher Chen

National University of Singapore

Albert J. Mills

Albert J. Mills

Saint Mary's University

Michael Morgan

Michael Morgan

University of Massachusetts Amherst

Something went wrong. Please try again later.